Skip to main content

Table 1 Antibiotics consumption intensity for the main classes of antibiotics in 145 hospitals

From: Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014

Class (ATC category) Antibiotics consumption intensity, median value (range, DDDs per 100 patient-days)
All antibiotics(J01) 46.30 (23.93–115.39)
Beta-lactams(J01C + J01D) 33.03 (19.35–67.05)
Beta-lactam-beta-lactamase inhibitor combinations 7.34 (0.73–34.33)
Beta-lactams excluding CBLI 25.95 (13.48–58.82)
Penicillins(J01C) 5.69 (0.99–23.21)
Penicillins excluding CBLI 2.40 (0.02–21.89)
Cephalosporins (J01DB + J01DC + J01DD + J01DE) 24.70 (10.81–52.52)
Cephalosporins excluding CBLI 19.82 (9.20–51.38)
3-GC(J01DD) 10.99 (2.57–38.98)
3GC excluding CBLI 5.99 (1.05–20.99)
4-GC(J01DE) 0.30 (0–5.98)
Carbapenems(J01DH) 1.95 (0.17–10.06)
Fluoroquinolones(J01MA) 5.70 (1.58–19.25)
Ciprofloxacin (J01MA02) 0.09 (0–2.80)
Levofloxacin (J01MA12) 3.73 (0.01–13.56)
Moxifloxacin (J01MA14) 1.41 (0–6.74)
  1. ATC Anatomic Therapeutic Chemical; DDDs defined daily dosages; CBLI combinations with beta-lactamase inhibitors; 3-GC the third generation cephalosporins; 4-GC the fourth generation cephalosporins.